UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022291
Receipt number R000018632
Scientific Title The relationship between end-tidal sevoflurane concentration and threshold current of motor-evoked potential(MEP) under general anesthesia with propofol and remifentanil
Date of disclosure of the study information 2016/05/30
Last modified on 2023/04/14 10:53:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The relationship between end-tidal sevoflurane concentration and threshold current of motor-evoked potential(MEP) under general anesthesia with propofol and remifentanil

Acronym

The relationship between end-tidal sevoflurane concentration and threshold current of motor-evoked potential(MEP)

Scientific Title

The relationship between end-tidal sevoflurane concentration and threshold current of motor-evoked potential(MEP) under general anesthesia with propofol and remifentanil

Scientific Title:Acronym

The relationship between end-tidal sevoflurane concentration and threshold current of motor-evoked potential(MEP)

Region

Japan


Condition

Condition

spine surgery

Classification by specialty

Orthopedics Anesthesiology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To demonstrate the relationship between concentration of end-tidal sevoflurane and MEP threshold current under general anesthesia.

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Sevoflurane is combined at end-tidal concentration of 0.5, 1, 1.5 and 2% with propofol and remifentanil for general anesthesia and MEP threshold current is measured respectively after five minutes steady state.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Sevoflurane is combined at end-tidal concentration of 0.5, 1, 1.5 and 2% with propofol and remifentanil for general anesthesia and MEP threshold current is measured respectively.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients undergoing spine surgery

Key exclusion criteria

Patients with motor palarysis
Patients with comorbidity American Society of Anesthesiologists physical status(ASA-PS)3 or more
Patients whom investigators consider to be ineligible

Target sample size

100


Research contact person

Name of lead principal investigator

1st name TAKEHIKO
Middle name
Last name NAGAOKA

Organization

Shin-yurigaoka General Hospital

Division name

Anesthesia

Zip code

2150026

Address

255 furusawa-toko, Asao, Kawasaki, Kanagawa

TEL

0443229991

Email

takeitezzz@gmail.com


Public contact

Name of contact person

1st name TAKEHIKO
Middle name
Last name NAGAOKA

Organization

Shin-yurigaoka General Hospital

Division name

Anesthesia

Zip code

2150026

Address

255 furusawa-toko, Asao, Kawasaki, Kanagawa

TEL

0443229991

Homepage URL


Email

takeitezzz@gmail.com


Sponsor or person

Institute

Shin-yurigaoka general hospital

Institute

Department

Personal name



Funding Source

Organization

Our institution

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shin-Yurigaoka General Hospital

Address

255 Furusawatoko, Asao, Kawasaki, Kanagawa, Japan

Tel

0443229991

Email

shinyuri_info@mt.strins.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 05 Month 12 Day

Last modified on

2023 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018632


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name